# Influence of PepF peptidase and sporulation on microcin J25 production in Bacillus subtilis

**Authors:** Guangwen Zhang, Saixiang Feng, Miaomiao Qin, Juan Sun, Yutong Liu, Changqi Luo, Min Lin, Siqi Xu, Ming Liao, Huiying Fan, Zhaoping Liang

PMC · DOI: 10.1128/spectrum.03748-23 · 2024-05-23

## TL;DR

This study shows how modifying peptidase PepF and sporulation in Bacillus subtilis can boost production of the antibacterial microcin J25.

## Contribution

The study identifies PepF peptidase and sporulation as key factors limiting MccJ25 accumulation in B. subtilis and provides engineered strains with improved production.

## Key findings

- Disruption of the pepF gene increases MccJ25 concentration to 1.68 µM in B. subtilis.
- MccJ25 production downregulates sporulation-related genes in B. subtilis.
- Engineered B. subtilis strains with ΔpepF and ΔsigF mutations improve MccJ25 stability and yield.

## Abstract

The lasso peptide microcin J25 (MccJ25) possesses strong antibacterial properties and is considered a potential effective component of bacterial disease treatment drugs and safe food preservatives. Although MccJ25 can be heterologously expressed in Bacillus subtilis as we have previously reported, its regulation and accumulation are yet to be understood. Here, we investigated the expression level and stability of MccJ25 in B. subtilis strains with disruption in peptidase genes pepA, pepF, and pepT. Oligoendopeptidase F (PepF) was found to be involved in reduction of the production of MccJ25 by degradation of its precursor peptide. In the pepF mutant, the MccJ25 reached a concentration of 1.68 µM after a cultivation time exceeding 60 hours, while the wild-type strain exhibited a concentration of only 0.14 µM. Moreover, the production of MccJ25 in B. subtilis downregulated the genes associated with sporulation, and this may contribute to its accumulation. Finally, this study provides a strategy to improve the stability and production of MccJ25 in B. subtilis.

MccJ25 displays significant antibacterial activity, a well-defined mode of action, exceptional safety, and remarkable stability. Hence, it presents itself as a compelling candidate for an optimal antibacterial or anti-endotoxin medication. The successful establishment of exogenous production of MccJ25 in Bacillus subtilis provides a strategy for reducing its production cost and diversifying its utilization. In this study, we have provided evidence indicating that both peptidase PepF and sporulation are significant factors that limit the expression of MccJ25 in B. subtilis. The ΔpepF and ΔsigF mutants of B. subtilis express MccJ25 with higher production yield and enhanced stability. To sum up, this study developed several better engineered strains of B. subtilis, which greatly reduced the consumption of MccJ25 during the nutrient depletion stage of the host strain, improved its production, and elucidated factors that may be involved in reducing MccJ25 accumulation in B. subtilis.

## Linked entities

- **Genes:** CNDP2 (carnosine dipeptidase 2) [NCBI Gene 55748], Pepf (pepsinogen F) [NCBI Gene 58803], pepT (peptidase T) [NCBI Gene 913326], SIGF (RNApolymerase sigma-subunit F) [NCBI Gene 818273]
- **Proteins:** Pepf (pepsinogen F)
- **Species:** Bacillus subtilis (taxon 1423)

## Full-text entities

- **Diseases:** bacterial disease (MESH:D001424)
- **Chemicals:** lasso (-)
- **Species:** Bacillus subtilis (species) [taxon 1423]

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11218540/full.md

---
Source: https://tomesphere.com/paper/PMC11218540